These results showed that the proliferation and migration of HCC cells may be altered by regulating the EFNA4-EPHA2-PIK3R2 axis associated with the GSK3β/β-catenin signaling pathway. The gene discussed is EPHA2; the disease is hepatocellular carcinoma.